COVID-19 Impact on Global Point of Care Infectious Disease Market Size, Status and Forecast 2020-2026

August 2020 | 133 pages | ID: C3B25A0861C0EN
QYResearch

Abstracts

This report focuses on the global Point of Care Infectious Disease status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Point of Care Infectious Disease development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Siemens Healthineers
• Trivitron Healthcare
• F. Hoffmann-La Roche Ltd
• Abbott
• Quest Diagnostics, Inc
• BD & Company
• Chembio Diagnostics Inc
• Trinity Biotech
• Cardinal Health
• Bio-Rad Labs Inc.
• bioM?rieux SA
• Thermo Fisher Scientific Inc
• Sight Diagnostics Ltd.
• Gene POC
• Ortho-Clinical Diagnostics
• OJ-Bio Ltd.

Market segment by Type, the product can be split into

• HIV POC
• Clostridium difficile POC
• HBV POC
• Pneumonia or Streptococcus associated infections
• Respiratory syncytial virus (RSV) POC
• HPV POC
• Influenza/Flu POC
• HCV POC
• MRSA POC
• TB and drug-resistant TB POC

Market segment by Application, split into

• Hospitals
• Clinics
• Home
• Assisted Living Healthcare Facilities
• Laboratories
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Point of Care Infectious Disease status, future forecast, growth opportunity, key market and key players.
• To present the Point of Care Infectious Disease development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Point of Care Infectious Disease are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Point of Care Infectious Disease Revenue
1.4 Market Analysis by Type
  1.4.1 Global Point of Care Infectious Disease Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 HIV POC
  1.4.3 Clostridium difficile POC
  1.4.4 HBV POC
  1.4.5 Pneumonia or Streptococcus associated infections
  1.4.6 Respiratory syncytial virus (RSV) POC
  1.4.7 HPV POC
  1.4.8 Influenza/Flu POC
  1.4.9 HCV POC
  1.4.10 MRSA POC
  1.4.11 TB and drug-resistant TB POC
1.5 Market by Application
  1.5.1 Global Point of Care Infectious Disease Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals
  1.5.3 Clinics
  1.5.4 Home
  1.5.5 Assisted Living Healthcare Facilities
  1.5.6 Laboratories
  1.5.7 Others
1.6 Coronavirus Disease 2019 (Covid-19): Point of Care Infectious Disease Industry Impact
  1.6.1 How the Covid-19 is Affecting the Point of Care Infectious Disease Industry
    1.6.1.1 Point of Care Infectious Disease Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Point of Care Infectious Disease Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Point of Care Infectious Disease Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Point of Care Infectious Disease Market Perspective (2015-2026)
2.2 Point of Care Infectious Disease Growth Trends by Regions
  2.2.1 Point of Care Infectious Disease Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Point of Care Infectious Disease Historic Market Share by Regions (2015-2020)
  2.2.3 Point of Care Infectious Disease Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Point of Care Infectious Disease Market Growth Strategy
  2.3.6 Primary Interviews with Key Point of Care Infectious Disease Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Point of Care Infectious Disease Players by Market Size
  3.1.1 Global Top Point of Care Infectious Disease Players by Revenue (2015-2020)
  3.1.2 Global Point of Care Infectious Disease Revenue Market Share by Players (2015-2020)
  3.1.3 Global Point of Care Infectious Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Point of Care Infectious Disease Market Concentration Ratio
  3.2.1 Global Point of Care Infectious Disease Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Point of Care Infectious Disease Revenue in 2019
3.3 Point of Care Infectious Disease Key Players Head office and Area Served
3.4 Key Players Point of Care Infectious Disease Product Solution and Service
3.5 Date of Enter into Point of Care Infectious Disease Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Point of Care Infectious Disease Historic Market Size by Type (2015-2020)
4.2 Global Point of Care Infectious Disease Forecasted Market Size by Type (2021-2026)

5 POINT OF CARE INFECTIOUS DISEASE BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Point of Care Infectious Disease Market Size by Application (2015-2020)
5.2 Global Point of Care Infectious Disease Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Point of Care Infectious Disease Market Size (2015-2020)
6.2 Point of Care Infectious Disease Key Players in North America (2019-2020)
6.3 North America Point of Care Infectious Disease Market Size by Type (2015-2020)
6.4 North America Point of Care Infectious Disease Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Point of Care Infectious Disease Market Size (2015-2020)
7.2 Point of Care Infectious Disease Key Players in Europe (2019-2020)
7.3 Europe Point of Care Infectious Disease Market Size by Type (2015-2020)
7.4 Europe Point of Care Infectious Disease Market Size by Application (2015-2020)

8 CHINA

8.1 China Point of Care Infectious Disease Market Size (2015-2020)
8.2 Point of Care Infectious Disease Key Players in China (2019-2020)
8.3 China Point of Care Infectious Disease Market Size by Type (2015-2020)
8.4 China Point of Care Infectious Disease Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Point of Care Infectious Disease Market Size (2015-2020)
9.2 Point of Care Infectious Disease Key Players in Japan (2019-2020)
9.3 Japan Point of Care Infectious Disease Market Size by Type (2015-2020)
9.4 Japan Point of Care Infectious Disease Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Point of Care Infectious Disease Market Size (2015-2020)
10.2 Point of Care Infectious Disease Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Point of Care Infectious Disease Market Size by Type (2015-2020)
10.4 Southeast Asia Point of Care Infectious Disease Market Size by Application (2015-2020)

11 INDIA

11.1 India Point of Care Infectious Disease Market Size (2015-2020)
11.2 Point of Care Infectious Disease Key Players in India (2019-2020)
11.3 India Point of Care Infectious Disease Market Size by Type (2015-2020)
11.4 India Point of Care Infectious Disease Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Point of Care Infectious Disease Market Size (2015-2020)
12.2 Point of Care Infectious Disease Key Players in Central & South America (2019-2020)
12.3 Central & South America Point of Care Infectious Disease Market Size by Type (2015-2020)
12.4 Central & South America Point of Care Infectious Disease Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Siemens Healthineers
  13.1.1 Siemens Healthineers Company Details
  13.1.2 Siemens Healthineers Business Overview and Its Total Revenue
  13.1.3 Siemens Healthineers Point of Care Infectious Disease Introduction
  13.1.4 Siemens Healthineers Revenue in Point of Care Infectious Disease Business (2015-2020))
  13.1.5 Siemens Healthineers Recent Development
13.2 Trivitron Healthcare
  13.2.1 Trivitron Healthcare Company Details
  13.2.2 Trivitron Healthcare Business Overview and Its Total Revenue
  13.2.3 Trivitron Healthcare Point of Care Infectious Disease Introduction
  13.2.4 Trivitron Healthcare Revenue in Point of Care Infectious Disease Business (2015-2020)
  13.2.5 Trivitron Healthcare Recent Development
13.3 F. Hoffmann-La Roche Ltd
  13.3.1 F. Hoffmann-La Roche Ltd Company Details
  13.3.2 F. Hoffmann-La Roche Ltd Business Overview and Its Total Revenue
  13.3.3 F. Hoffmann-La Roche Ltd Point of Care Infectious Disease Introduction
  13.3.4 F. Hoffmann-La Roche Ltd Revenue in Point of Care Infectious Disease Business (2015-2020)
  13.3.5 F. Hoffmann-La Roche Ltd Recent Development
13.4 Abbott
  13.4.1 Abbott Company Details
  13.4.2 Abbott Business Overview and Its Total Revenue
  13.4.3 Abbott Point of Care Infectious Disease Introduction
  13.4.4 Abbott Revenue in Point of Care Infectious Disease Business (2015-2020)
  13.4.5 Abbott Recent Development
13.5 Quest Diagnostics, Inc
  13.5.1 Quest Diagnostics, Inc Company Details
  13.5.2 Quest Diagnostics, Inc Business Overview and Its Total Revenue
  13.5.3 Quest Diagnostics, Inc Point of Care Infectious Disease Introduction
  13.5.4 Quest Diagnostics, Inc Revenue in Point of Care Infectious Disease Business (2015-2020)
  13.5.5 Quest Diagnostics, Inc Recent Development
13.6 BD & Company
  13.6.1 BD & Company Company Details
  13.6.2 BD & Company Business Overview and Its Total Revenue
  13.6.3 BD & Company Point of Care Infectious Disease Introduction
  13.6.4 BD & Company Revenue in Point of Care Infectious Disease Business (2015-2020)
  13.6.5 BD & Company Recent Development
13.7 Chembio Diagnostics Inc
  13.7.1 Chembio Diagnostics Inc Company Details
  13.7.2 Chembio Diagnostics Inc Business Overview and Its Total Revenue
  13.7.3 Chembio Diagnostics Inc Point of Care Infectious Disease Introduction
  13.7.4 Chembio Diagnostics Inc Revenue in Point of Care Infectious Disease Business (2015-2020)
  13.7.5 Chembio Diagnostics Inc Recent Development
13.8 Trinity Biotech
  13.8.1 Trinity Biotech Company Details
  13.8.2 Trinity Biotech Business Overview and Its Total Revenue
  13.8.3 Trinity Biotech Point of Care Infectious Disease Introduction
  13.8.4 Trinity Biotech Revenue in Point of Care Infectious Disease Business (2015-2020)
  13.8.5 Trinity Biotech Recent Development
13.9 Cardinal Health
  13.9.1 Cardinal Health Company Details
  13.9.2 Cardinal Health Business Overview and Its Total Revenue
  13.9.3 Cardinal Health Point of Care Infectious Disease Introduction
  13.9.4 Cardinal Health Revenue in Point of Care Infectious Disease Business (2015-2020)
  13.9.5 Cardinal Health Recent Development
13.10 Bio-Rad Labs Inc.
  13.10.1 Bio-Rad Labs Inc. Company Details
  13.10.2 Bio-Rad Labs Inc. Business Overview and Its Total Revenue
  13.10.3 Bio-Rad Labs Inc. Point of Care Infectious Disease Introduction
  13.10.4 Bio-Rad Labs Inc. Revenue in Point of Care Infectious Disease Business (2015-2020)
  13.10.5 Bio-Rad Labs Inc. Recent Development
13.11 bioM?rieux SA
  10.11.1 bioM?rieux SA Company Details
  10.11.2 bioM?rieux SA Business Overview and Its Total Revenue
  10.11.3 bioM?rieux SA Point of Care Infectious Disease Introduction
  10.11.4 bioM?rieux SA Revenue in Point of Care Infectious Disease Business (2015-2020)
  10.11.5 bioM?rieux SA Recent Development
13.12 Thermo Fisher Scientific Inc
  10.12.1 Thermo Fisher Scientific Inc Company Details
  10.12.2 Thermo Fisher Scientific Inc Business Overview and Its Total Revenue
  10.12.3 Thermo Fisher Scientific Inc Point of Care Infectious Disease Introduction
  10.12.4 Thermo Fisher Scientific Inc Revenue in Point of Care Infectious Disease Business (2015-2020)
  10.12.5 Thermo Fisher Scientific Inc Recent Development
13.13 Sight Diagnostics Ltd.
  10.13.1 Sight Diagnostics Ltd. Company Details
  10.13.2 Sight Diagnostics Ltd. Business Overview and Its Total Revenue
  10.13.3 Sight Diagnostics Ltd. Point of Care Infectious Disease Introduction
  10.13.4 Sight Diagnostics Ltd. Revenue in Point of Care Infectious Disease Business (2015-2020)
  10.13.5 Sight Diagnostics Ltd. Recent Development
13.14 Gene POC
  10.14.1 Gene POC Company Details
  10.14.2 Gene POC Business Overview and Its Total Revenue
  10.14.3 Gene POC Point of Care Infectious Disease Introduction
  10.14.4 Gene POC Revenue in Point of Care Infectious Disease Business (2015-2020)
  10.14.5 Gene POC Recent Development
13.15 Ortho-Clinical Diagnostics
  10.15.1 Ortho-Clinical Diagnostics Company Details
  10.15.2 Ortho-Clinical Diagnostics Business Overview and Its Total Revenue
  10.15.3 Ortho-Clinical Diagnostics Point of Care Infectious Disease Introduction
  10.15.4 Ortho-Clinical Diagnostics Revenue in Point of Care Infectious Disease Business (2015-2020)
  10.15.5 Ortho-Clinical Diagnostics Recent Development
13.16 OJ-Bio Ltd.
  10.16.1 OJ-Bio Ltd. Company Details
  10.16.2 OJ-Bio Ltd. Business Overview and Its Total Revenue
  10.16.3 OJ-Bio Ltd. Point of Care Infectious Disease Introduction
  10.16.4 OJ-Bio Ltd. Revenue in Point of Care Infectious Disease Business (2015-2020)
  10.16.5 OJ-Bio Ltd. Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Point of Care Infectious Disease Key Market Segments
Table 2. Key Players Covered: Ranking by Point of Care Infectious Disease Revenue
Table 3. Ranking of Global Top Point of Care Infectious Disease Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Point of Care Infectious Disease Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of HIV POC
Table 6. Key Players of Clostridium difficile POC
Table 7. Key Players of HBV POC
Table 8. Key Players of Pneumonia or Streptococcus associated infections
Table 9. Key Players of Respiratory syncytial virus (RSV) POC
Table 10. Key Players of HPV POC
Table 11. Key Players of Influenza/Flu POC
Table 12. Key Players of HCV POC
Table 13. Key Players of MRSA POC
Table 14. Key Players of TB and drug-resistant TB POC
Table 15. COVID-19 Impact Global Market: (Four Point of Care Infectious Disease Market Size Forecast Scenarios)
Table 16. Opportunities and Trends for Point of Care Infectious Disease Players in the COVID-19 Landscape
Table 17. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 18. Key Regions/Countries Measures against Covid-19 Impact
Table 19. Proposal for Point of Care Infectious Disease Players to Combat Covid-19 Impact
Table 20. Global Point of Care Infectious Disease Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 21. Global Point of Care Infectious Disease Market Size by Regions (US$ Million): 2020 VS 2026
Table 22. Global Point of Care Infectious Disease Market Size by Regions (2015-2020) (US$ Million)
Table 23. Global Point of Care Infectious Disease Market Share by Regions (2015-2020)
Table 24. Global Point of Care Infectious Disease Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 25. Global Point of Care Infectious Disease Market Share by Regions (2021-2026)
Table 26. Market Top Trends
Table 27. Key Drivers: Impact Analysis
Table 28. Key Challenges
Table 29. Point of Care Infectious Disease Market Growth Strategy
Table 30. Main Points Interviewed from Key Point of Care Infectious Disease Players
Table 31. Global Point of Care Infectious Disease Revenue by Players (2015-2020) (Million US$)
Table 32. Global Point of Care Infectious Disease Market Share by Players (2015-2020)
Table 33. Global Top Point of Care Infectious Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Point of Care Infectious Disease as of 2019)
Table 34. Global Point of Care Infectious Disease by Players Market Concentration Ratio (CR5 and HHI)
Table 35. Key Players Headquarters and Area Served
Table 36. Key Players Point of Care Infectious Disease Product Solution and Service
Table 37. Date of Enter into Point of Care Infectious Disease Market
Table 38. Mergers & Acquisitions, Expansion Plans
Table 39. Global Point of Care Infectious Disease Market Size by Type (2015-2020) (Million US$)
Table 40. Global Point of Care Infectious Disease Market Size Share by Type (2015-2020)
Table 41. Global Point of Care Infectious Disease Revenue Market Share by Type (2021-2026)
Table 42. Global Point of Care Infectious Disease Market Size Share by Application (2015-2020)
Table 43. Global Point of Care Infectious Disease Market Size by Application (2015-2020) (Million US$)
Table 44. Global Point of Care Infectious Disease Market Size Share by Application (2021-2026)
Table 45. North America Key Players Point of Care Infectious Disease Revenue (2019-2020) (Million US$)
Table 46. North America Key Players Point of Care Infectious Disease Market Share (2019-2020)
Table 47. North America Point of Care Infectious Disease Market Size by Type (2015-2020) (Million US$)
Table 48. North America Point of Care Infectious Disease Market Share by Type (2015-2020)
Table 49. North America Point of Care Infectious Disease Market Size by Application (2015-2020) (Million US$)
Table 50. North America Point of Care Infectious Disease Market Share by Application (2015-2020)
Table 51. Europe Key Players Point of Care Infectious Disease Revenue (2019-2020) (Million US$)
Table 52. Europe Key Players Point of Care Infectious Disease Market Share (2019-2020)
Table 53. Europe Point of Care Infectious Disease Market Size by Type (2015-2020) (Million US$)
Table 54. Europe Point of Care Infectious Disease Market Share by Type (2015-2020)
Table 55. Europe Point of Care Infectious Disease Market Size by Application (2015-2020) (Million US$)
Table 56. Europe Point of Care Infectious Disease Market Share by Application (2015-2020)
Table 57. China Key Players Point of Care Infectious Disease Revenue (2019-2020) (Million US$)
Table 58. China Key Players Point of Care Infectious Disease Market Share (2019-2020)
Table 59. China Point of Care Infectious Disease Market Size by Type (2015-2020) (Million US$)
Table 60. China Point of Care Infectious Disease Market Share by Type (2015-2020)
Table 61. China Point of Care Infectious Disease Market Size by Application (2015-2020) (Million US$)
Table 62. China Point of Care Infectious Disease Market Share by Application (2015-2020)
Table 63. Japan Key Players Point of Care Infectious Disease Revenue (2019-2020) (Million US$)
Table 64. Japan Key Players Point of Care Infectious Disease Market Share (2019-2020)
Table 65. Japan Point of Care Infectious Disease Market Size by Type (2015-2020) (Million US$)
Table 66. Japan Point of Care Infectious Disease Market Share by Type (2015-2020)
Table 67. Japan Point of Care Infectious Disease Market Size by Application (2015-2020) (Million US$)
Table 68. Japan Point of Care Infectious Disease Market Share by Application (2015-2020)
Table 69. Southeast Asia Key Players Point of Care Infectious Disease Revenue (2019-2020) (Million US$)
Table 70. Southeast Asia Key Players Point of Care Infectious Disease Market Share (2019-2020)
Table 71. Southeast Asia Point of Care Infectious Disease Market Size by Type (2015-2020) (Million US$)
Table 72. Southeast Asia Point of Care Infectious Disease Market Share by Type (2015-2020)
Table 73. Southeast Asia Point of Care Infectious Disease Market Size by Application (2015-2020) (Million US$)
Table 74. Southeast Asia Point of Care Infectious Disease Market Share by Application (2015-2020)
Table 75. India Key Players Point of Care Infectious Disease Revenue (2019-2020) (Million US$)
Table 76. India Key Players Point of Care Infectious Disease Market Share (2019-2020)
Table 77. India Point of Care Infectious Disease Market Size by Type (2015-2020) (Million US$)
Table 78. India Point of Care Infectious Disease Market Share by Type (2015-2020)
Table 79. India Point of Care Infectious Disease Market Size by Application (2015-2020) (Million US$)
Table 80. India Point of Care Infectious Disease Market Share by Application (2015-2020)
Table 81. Central & South America Key Players Point of Care Infectious Disease Revenue (2019-2020) (Million US$)
Table 82. Central & South America Key Players Point of Care Infectious Disease Market Share (2019-2020)
Table 83. Central & South America Point of Care Infectious Disease Market Size by Type (2015-2020) (Million US$)
Table 84. Central & South America Point of Care Infectious Disease Market Share by Type (2015-2020)
Table 85. Central & South America Point of Care Infectious Disease Market Size by Application (2015-2020) (Million US$)
Table 86. Central & South America Point of Care Infectious Disease Market Share by Application (2015-2020)
Table 87. Siemens Healthineers Company Details
Table 88. Siemens Healthineers Business Overview
Table 89. Siemens Healthineers Product
Table 90. Siemens Healthineers Revenue in Point of Care Infectious Disease Business (2015-2020) (Million US$)
Table 91. Siemens Healthineers Recent Development
Table 92. Trivitron Healthcare Company Details
Table 93. Trivitron Healthcare Business Overview
Table 94. Trivitron Healthcare Product
Table 95. Trivitron Healthcare Revenue in Point of Care Infectious Disease Business (2015-2020) (Million US$)
Table 96. Trivitron Healthcare Recent Development
Table 97. F. Hoffmann-La Roche Ltd Company Details
Table 98. F. Hoffmann-La Roche Ltd Business Overview
Table 99. F. Hoffmann-La Roche Ltd Product
Table 100. F. Hoffmann-La Roche Ltd Revenue in Point of Care Infectious Disease Business (2015-2020) (Million US$)
Table 101. F. Hoffmann-La Roche Ltd Recent Development
Table 102. Abbott Company Details
Table 103. Abbott Business Overview
Table 104. Abbott Product
Table 105. Abbott Revenue in Point of Care Infectious Disease Business (2015-2020) (Million US$)
Table 106. Abbott Recent Development
Table 107. Quest Diagnostics, Inc Company Details
Table 108. Quest Diagnostics, Inc Business Overview
Table 109. Quest Diagnostics, Inc Product
Table 110. Quest Diagnostics, Inc Revenue in Point of Care Infectious Disease Business (2015-2020) (Million US$)
Table 111. Quest Diagnostics, Inc Recent Development
Table 112. BD & Company Company Details
Table 113. BD & Company Business Overview
Table 114. BD & Company Product
Table 115. BD & Company Revenue in Point of Care Infectious Disease Business (2015-2020) (Million US$)
Table 116. BD & Company Recent Development
Table 117. Chembio Diagnostics Inc Company Details
Table 118. Chembio Diagnostics Inc Business Overview
Table 119. Chembio Diagnostics Inc Product
Table 120. Chembio Diagnostics Inc Revenue in Point of Care Infectious Disease Business (2015-2020) (Million US$)
Table 121. Chembio Diagnostics Inc Recent Development
Table 122. Trinity Biotech Business Overview
Table 123. Trinity Biotech Product
Table 124. Trinity Biotech Company Details
Table 125. Trinity Biotech Revenue in Point of Care Infectious Disease Business (2015-2020) (Million US$)
Table 126. Trinity Biotech Recent Development
Table 127. Cardinal Health Company Details
Table 128. Cardinal Health Business Overview
Table 129. Cardinal Health Product
Table 130. Cardinal Health Revenue in Point of Care Infectious Disease Business (2015-2020) (Million US$)
Table 131. Cardinal Health Recent Development
Table 132. Bio-Rad Labs Inc. Company Details
Table 133. Bio-Rad Labs Inc. Business Overview
Table 134. Bio-Rad Labs Inc. Product
Table 135. Bio-Rad Labs Inc. Revenue in Point of Care Infectious Disease Business (2015-2020) (Million US$)
Table 136. Bio-Rad Labs Inc. Recent Development
Table 137. bioM?rieux SA Company Details
Table 138. bioM?rieux SA Business Overview
Table 139. bioM?rieux SA Product
Table 140. bioM?rieux SA Revenue in Point of Care Infectious Disease Business (2015-2020) (Million US$)
Table 141. bioM?rieux SA Recent Development
Table 142. Thermo Fisher Scientific Inc Company Details
Table 143. Thermo Fisher Scientific Inc Business Overview
Table 144. Thermo Fisher Scientific Inc Product
Table 145. Thermo Fisher Scientific Inc Revenue in Point of Care Infectious Disease Business (2015-2020) (Million US$)
Table 146. Thermo Fisher Scientific Inc Recent Development
Table 147. Sight Diagnostics Ltd. Company Details
Table 148. Sight Diagnostics Ltd. Business Overview
Table 149. Sight Diagnostics Ltd. Product
Table 150. Sight Diagnostics Ltd. Revenue in Point of Care Infectious Disease Business (2015-2020) (Million US$)
Table 151. Sight Diagnostics Ltd. Recent Development
Table 152. Gene POC Company Details
Table 153. Gene POC Business Overview
Table 154. Gene POC Product
Table 155. Gene POC Revenue in Point of Care Infectious Disease Business (2015-2020) (Million US$)
Table 156. Gene POC Recent Development
Table 157. Ortho-Clinical Diagnostics Company Details
Table 158. Ortho-Clinical Diagnostics Business Overview
Table 159. Ortho-Clinical Diagnostics Product
Table 160. Ortho-Clinical Diagnostics Revenue in Point of Care Infectious Disease Business (2015-2020) (Million US$)
Table 161. Ortho-Clinical Diagnostics Recent Development
Table 162. OJ-Bio Ltd. Company Details
Table 163. OJ-Bio Ltd. Business Overview
Table 164. OJ-Bio Ltd. Product
Table 165. OJ-Bio Ltd. Revenue in Point of Care Infectious Disease Business (2015-2020) (Million US$)
Table 166. OJ-Bio Ltd. Recent Development
Table 167. Research Programs/Design for This Report
Table 168. Key Data Information from Secondary Sources
Table 169. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Point of Care Infectious Disease Market Share by Type: 2020 VS 2026
Figure 2. HIV POC Features
Figure 3. Clostridium difficile POC Features
Figure 4. HBV POC Features
Figure 5. Pneumonia or Streptococcus associated infections Features
Figure 6. Respiratory syncytial virus (RSV) POC Features
Figure 7. HPV POC Features
Figure 8. Influenza/Flu POC Features
Figure 9. HCV POC Features
Figure 10. MRSA POC Features
Figure 11. TB and drug-resistant TB POC Features
Figure 12. Global Point of Care Infectious Disease Market Share by Application: 2020 VS 2026
Figure 13. Hospitals Case Studies
Figure 14. Clinics Case Studies
Figure 15. Home Case Studies
Figure 16. Assisted Living Healthcare Facilities Case Studies
Figure 17. Laboratories Case Studies
Figure 18. Others Case Studies
Figure 19. Point of Care Infectious Disease Report Years Considered
Figure 20. Global Point of Care Infectious Disease Market Size YoY Growth 2015-2026 (US$ Million)
Figure 21. Global Point of Care Infectious Disease Market Share by Regions: 2020 VS 2026
Figure 22. Global Point of Care Infectious Disease Market Share by Regions (2021-2026)
Figure 23. Porter's Five Forces Analysis
Figure 24. Global Point of Care Infectious Disease Market Share by Players in 2019
Figure 25. Global Top Point of Care Infectious Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Point of Care Infectious Disease as of 2019
Figure 26. The Top 10 and 5 Players Market Share by Point of Care Infectious Disease Revenue in 2019
Figure 27. North America Point of Care Infectious Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Europe Point of Care Infectious Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. China Point of Care Infectious Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 30. Japan Point of Care Infectious Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 31. Southeast Asia Point of Care Infectious Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 32. India Point of Care Infectious Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 33. Central & South America Point of Care Infectious Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 34. Siemens Healthineers Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Siemens Healthineers Revenue Growth Rate in Point of Care Infectious Disease Business (2015-2020)
Figure 36. Trivitron Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Trivitron Healthcare Revenue Growth Rate in Point of Care Infectious Disease Business (2015-2020)
Figure 38. F. Hoffmann-La Roche Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Point of Care Infectious Disease Business (2015-2020)
Figure 40. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Abbott Revenue Growth Rate in Point of Care Infectious Disease Business (2015-2020)
Figure 42. Quest Diagnostics, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Quest Diagnostics, Inc Revenue Growth Rate in Point of Care Infectious Disease Business (2015-2020)
Figure 44. BD & Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. BD & Company Revenue Growth Rate in Point of Care Infectious Disease Business (2015-2020)
Figure 46. Chembio Diagnostics Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Chembio Diagnostics Inc Revenue Growth Rate in Point of Care Infectious Disease Business (2015-2020)
Figure 48. Trinity Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Trinity Biotech Revenue Growth Rate in Point of Care Infectious Disease Business (2015-2020)
Figure 50. Cardinal Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Cardinal Health Revenue Growth Rate in Point of Care Infectious Disease Business (2015-2020)
Figure 52. Bio-Rad Labs Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Bio-Rad Labs Inc. Revenue Growth Rate in Point of Care Infectious Disease Business (2015-2020)
Figure 54. bioM?rieux SA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. bioM?rieux SA Revenue Growth Rate in Point of Care Infectious Disease Business (2015-2020)
Figure 56. Thermo Fisher Scientific Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Thermo Fisher Scientific Inc Revenue Growth Rate in Point of Care Infectious Disease Business (2015-2020)
Figure 58. Sight Diagnostics Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Sight Diagnostics Ltd. Revenue Growth Rate in Point of Care Infectious Disease Business (2015-2020)
Figure 60. Gene POC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Gene POC Revenue Growth Rate in Point of Care Infectious Disease Business (2015-2020)
Figure 62. Ortho-Clinical Diagnostics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Ortho-Clinical Diagnostics Revenue Growth Rate in Point of Care Infectious Disease Business (2015-2020)
Figure 64. OJ-Bio Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. OJ-Bio Ltd. Revenue Growth Rate in Point of Care Infectious Disease Business (2015-2020)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed